Acquisition of hepatitis C by a conjunctival splash

American Journal of Infection Control

Volumn 25, Issue 3, 1997, Pages 242-247

  Rosen, Hugo R ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ADULT; ANAMNESIS; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CONJUNCTIVA DISEASE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; INFECTION RISK; LIVER FUNCTION TEST; MALE;

EID: 0030950721     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-6553(97)90011-0     Document Type: Article

References (37)

1. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334:1691-6.
2. Rosen HR, Friedman LS, Martin P. Hepatitis C in renal dialysis and transplant patients. Viral Hepatitis Rev 1996;2:97-110.
3. Rosen HR, Shackleton CR, Martin P. Indications for and timing of liver transplantation. Med Clin North Am 1996;80:1069-102.
4. Alter HJ. To C or not to C: these are the questions. Blood 1995;85:1681-95.
5. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995;15:5-14.
6. Thomas DL, Vlahov D, Solomon L, et al. Correlates of hepatitis C infections among injection drug users. Medicine 1995;74:212-20.
7. Garfein RS, Vlahov D, Galai N, Doherry MC, Nelson KE. Viral infections in short-term injection drug users. Am J Public Health 1996;86:655-61.
8. Esteban JI, Gomez J, Martell M, Cabot B, et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996;334:555-60.
9. Sartori M, LaTerra G, Aglietta M, Manzin A, Navino C, Verzetti G. Transmission of hepatitis C via blood splash into conjunctiva [letter]. Scand J Infect Dis 1993;25:270-1.
10. Gerberding JL. Management of occupational exposures to blood-borne viruses. N Engl J Med 1995;332:444-51.
11. Henderson DK. Postexposure prophylaxis for occupational exposures to hepatitis B, hepatitis C, and human immunodeficiency virus. Surg Clin North Am 1995;75:1175-85.
12. Bjoro K, Froland SS, Yun Z, Samdal HH, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994;331:1607-11.
13. Alberti A, Chemello L, Cavalletto D, et al. Antibody to hepatitis C virus and liver disease in volunteer blood donors. Ann Intern Med 1991;114:1010-2.
14. Estaban JT, Genesca J, Alter HJ. Hepatitis C: molecular biology, pathogenesis, epidemiology, clinical features, and prevention. Progr Liver Dis 1992;10:252-82.
15. deMedina M, Schiff ER. Hepatitis C: diagnostic assays. Semin Liver Dis 1995;15:33-40.
16. DiBisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Longterm clinical and histopathological follow-up of chronic post-transfusion hepatitis. Hepatology 1991;14:969-74.
17. Healey CJ, Chapman RW, Fleming KA. Liver histology in hepatitis C infection: a comparison between patients with persistently normal or abnormal transaminases. Gut 1996;37:274-8.
18. Kiyosawa K, Akahane Y, Nagata A, Koike Y, Furata S. The significance of blood transfusion in non-A, non-B chronic liver disease in Japan. Vox Sang 1982;43:45-52.
19. Seeff LB, Buskell-Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 1992;327:1906-11.
20. Mutations in the nonstructural protein 5A gene and response to Interferon in patients with chronic hepatitis C virus Ib infection. N Engl J Med 1996;334:77-81.
21. Dusheiko G, Schmilovitz-Weiss H, Brown D, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 1994;19:13-8.
22. Rosen HR, Gretch DR, Flora KD, delaRosa C, Corless CL, Rabkin JM, et al. Molecular epidemiology of hepatitis C infection in U.S. veteran liver transplant recipients [abstract 296A]. Hepatology 1996;23(suppl):296A.
23. Suzuki K, Mizokami M, Lau JYN, Mizoguchi N, Kato K, et al. Confirmation of hepatitis C virus transmission through needlestick accidents by molecular evolutionary analysis. J Infect Dis 1994;170:1575-8.
24. Pozzato G, Kaneko S, Moretti M, et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994;43:291-6.
25. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis 1995;15:41-63.
26. Koziel MJ, Liang TJ. Vaccination against hepatitis C virus infection: miles to go before we sleep. Hepatology 1994;20:758-9.
27. Fried MW, Hoofnagle JH. Therapy of hepatitis C. Semin Liver Dis 1995;15:82-91.
28. Marcellin P, Martinot M, Pouteau M, Casteineu C, Boyer C, et al. HCV genotype and pretreatment HCV RNA levels are the main and independent prognostic factors of sustained response to interferon in chronic hepatitis C [abstract]. Hepatology 1994;20:246A.
29. Omata M, Yokosuka O, Takano S, et al. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991;338:914-5.
30. Poynard T, Bedosssa P, Chevallier M, et al. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995;332:1457-62.
31. Carreno V, Quiroga JA. New and forthcoming therapies for viral hepatitis. J Hepatol 1996;24:74-6.
32. Smith JP. Treatment of chronic hepatitis C with amantadine-hydrochloride [abstract 1330-A]. Gastroenterology 1996;110(suppl):A1330.
33. Alter MJ. Occupational exposure to hepatitis C virus: a dilemma. Infect Cont Hosp Epidemiol 1994;15:742-4.
34. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996;24:289-93.
35. Centers for Disease Control. Hepatitis surveillance report. 1996;56:36.
36. Spengler U, Lechmann M, Irrgang B, Dumoulin FL, Sauerbruch T. Immune responses in hepatitis C virus infection. J Hepatol 1996;24:20-5.
37. Zein NN, Persing DH. Hepatitis C genotypes: Current trends and future implications. Mayo Clin Proc 1996;71:458-62.